Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway

Journal of Biological Chemistry

Volumn 288, Issue 9, 2013, Pages 6552-6560

  Yang, Fang ^a   Zhang, Weimin ^a   Li, Dan ^a   Zhan, Qimin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN EMBRYO; CHORIOALLANTOIC MEMBRANE ASSAYS; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); MICROVESSEL DENSITY; OVER-EXPRESSION; PROTEIN PATHWAYS; TRANSCRIPTIONAL ACTIVITY; TUBE FORMATION; TUMOR ANGIOGENESIS; UNDERLYING MECHANISM;

ANTIBIOTICS; ASSOCIATION REACTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION; PHOSPHORYLATION;

TUMORS;

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SERINE; STAT3 PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL MIGRATION; CHICKEN; CHORIOALLANTOIS; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHICK EMBRYO; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874786609     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.418335     Document Type: Article

References (30)

1. Jin, S., Antinore, M. J., Lung, F. D., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., Jr., and Zhan, Q. (2000) The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem. 275, 16602-16608
2. Tong, T., Ji, J., Jin, S., Li, X., Fan, W., Song, Y., Wang, M., Liu, Z., Wu, M., and Zhan, Q. (2005) Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol. Cell. Biol. 25, 4488-4500
3. Carrier, F., Georgel, P. T., Pourquier, P., Blake, M., Kontny, H. U., Antinore, M. J., Gariboldi, M., Myers, T. G., Weinstein, J. N., Pommier, Y., and Fornace, A. J., Jr. (1999) Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol. Cell. Biol. 19, 1673-1685
4. Hildesheim, J., Bulavin, D. V., Anver, M. R., Alvord, W. G., Hollander, M. C., Vardanian, L., and Fornace, A. J., Jr. (2002) Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62, 7305-7315
5. Hollander, M. C., Sheikh, M. S., Bulavin, D. V., Lundgren, K., Augeri- Henmueller, L., Shehee, R., Molinaro, T. A., Kim, K. E., Tolosa, E., Ashwell, J. D., Rosenberg, M. P., Zhan, Q., Fernández-Salguero, P. M., Morgan, W. F., Deng, C. X., and Fornace, A. J., Jr. (1999) Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23, 176-184
6. Wang, W., Huper, G., Guo, Y., Murphy, S. K., Olson, J. A., Jr., and Marks, J. R. (2005) Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene 24, 2705-2714
7. Yamasawa, K., Nio, Y., Dong, M., Yamaguchi, K., and Itakura, M. (2002) Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin. Cancer Res. 8, 2563-2569
8. Ramachandran, K., Gopisetty, G., Gordian, E., Navarro, L., Hader, C., Reis, I. M., Schulz, W. A., and Singal, R. (2009) Methylation-mediated repression of GADD45α in prostate cancer and its role as a potential therapeutic target. Cancer Res. 69, 1527-1535
9. Hildesheim, J., Belova, G. I., Tyner, S. D., Zhou, X., Vardanian, L., and Fornace, A. J., Jr. (2004) Gadd45a regulates matrix metalloproteinases by suppressing ΔNp63α and β-catenin via p38 MAP kinase and APC complex activation. Oncogene 23, 1829-1837
10. Ji, J., Liu, R., Tong, T., Song, Y., Jin, S., Wu, M., and Zhan, Q. (2007) Gadd45a regulates β-catenin distribution and maintains cell-cell adhesion/contact. Oncogene 26, 6396-6405
11. Hollander, M. C., Kovalsky, O., Salvador, J. M., Kim, K. E., Patterson, A. D., Haines, D. C., and Fornace, A. J., Jr. (2001) Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res. 61, 2487-2491
12. Folkman, J. (1971) Tumor angiogenesis. Therapeutic implications. N. Engl. J. Med. 285, 1182-1186
13. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., and Darnell, J. E., Jr. (1999) Stat3 as an oncogene. Cell 98, 295-303
14. Yu, H., Kortylewski, M., and Pardoll, D. (2007) Crosstalk between cancer and immune cells. Role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41-51
15. Yan, S., Zhou, C., Zhang, W., Zhang, G., Zhao, X., Yang, S., Wang, Y., Lu, N., Zhu, H., and Xu, N. (2008) β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett. 271, 85-97
16. Chen, C. L., Hsieh, F. C., Lieblein, J. C., Brown, J., Chan, C., Wallace, J. A., Cheng, G., Hall, B. M., and Lin, J. (2007) Stat3 activation in human endometrial and cervical cancers. Br. J. Cancer 96, 591-599
17. Wen, Z., Zhong, Z., and Darnell, J. E., Jr. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250
18. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10, 47-50
19. Guertin, D. A., and Sabatini, D. M. (2007) Defining the role of mTOR in cancer. Cancer Cell 12, 9-22
20. Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., and Abraham, R. T. (2002) Regulation of hypoxiainducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7004-7014
21. Liu, A. M., Lo, R. K., Wong, C. S., Morris, C., Wise, H., and Wong, Y. H. (2006) Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase. J. Biol. Chem. 281, 35812-35825
22. Stamatovic, S. M., Keep, R. F., Mostarica-Stojkovic, M., and Andjelkovic, A. V. (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J. Immunol. 177, 2651-2661
23. Balasubramanian, S. P., Brown, N. J., and Reed, M. W. (2002) Role of genetic polymorphisms in tumour angiogenesis. Br. J. Cancer 87, 1057-1065
24. Cao, R., Bråkenhielm, E., Li, X., Pietras, K., Widenfalk, J., Ostman, A., Eriksson, U., and Cao, Y. (2002) Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors. FASEB J. 16, 1575-1583
25. Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., Heller, R., Ellis, L. M., Karras, J., Bromberg, J., Pardoll, D., Jove, R., and Yu, H. (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21, 2000-2008
26. Schindler, C., Levy, D. E., and Decker, T. (2007) JAK-STAT signaling. From interferons to cytokines. J. Biol. Chem. 282, 20059-20063
27. Takekawa, M., and Saito, H. (1998) A family of stress-inducible GADD45- like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521-530
28. Schuringa, J. J., Schepers, H., Vellenga, E., and Kruijer, W. (2001) Ser727- dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett. 495, 71-76
29. Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., Rueger, M. A., Bae, S. K., Kittappa, R., and McKay, R. D. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823-826
30. Inoki, K., Ouyang, H., Li, Y., and Guan, K. L. (2005) Signaling by target of rapamycin proteins in cell growth control. Microbiol. Mol. Biol. Rev. 69, 79-100